Therapure Biopharma Inc. Files Preliminary Prospectus for Initial Public Offering

MISSISSAUGA, Ontario–(BUSINESS WIRE)–Therapure Biopharma Inc. today announces that it has filed a preliminary prospectus with securities regulatory authorities in each of the provinces and territories of Canada in connection with a proposed initial public offering (the “Offering”) of its common shares. A copy of the preliminary prospectus is available on SEDAR (www.sedar.com). The Offering is being made through a syndicate of underwriters co-led by GMP Securities L.P., CIBC World Markets Inc.

Source:: http://feeds.businesswire.com/click.phdo?i=e6523e698ad56e82bd2cf9f38979428d

Print Friendly, PDF & Email

Share This

Share this post with your friends!